Aristotle University Of Thessaloniki (AUTH)
Η επίδραση της ενδοαυλικής εντερικής χορήγησης οξυγονωμένου φθοριοάνθρακα στην οξεία ισχαιμία και επαναιμάτωση του εντέρου: πειραματική μελέτη σε κονίκλους
Abstract
dc:descriptionIntestinal ischemia-reperfusion injury is a phenomenon often confronted in various surgical procedures, such as small bowel transplantation, abdominal aneurysm repair, necrotizing enterocolitis in neonates and in shock. It is associated with high morbidity and mortality rate which is above 50%. In recent years, it has been clear that the intestinal tract is one of the prime organs involved in ischemia-reperfusion injury. Multiple organ failure is a frequent complication after intestinal ischemia-reperfusion injury and is a common cause of death. A number of therapeutic approaches, that include radical scavengers and protease inhibitors, have been studied in order to reduce IR injury. Liquid perfluorocarbons (PFCs) are biologically inert compounds, well known for their high ability to carry respiratory gases from and towards the tissues, and have already been used in experimental studies of ischemia-reperfusion injury. The aim of this study is to evaluate the potential protective effect of intraluminal intestinal administration of oxygenated perfluorocarbons (PFC) on the enteric viability in an experimental model of acute ischemia-reperfusion (I/R). Twenty rabbits (White New Zealand, mean weight 2.500±3.500g) were divided randomly into four groups. Mesenteric ischemia was verified by Doppler examination, inspection of pale discoloration of the intestine and loss of pulses of the mesenteric circulation. The duration of ischemia was 120 min, followed by 60 min of reperfusion. Venous blood samples and antimesenteric wedge intestinal biopsies were taken at time 0, 60 min, 120 min (ischemia period), 150 min and 180 min, in order to determine quantitatively parameters involved in the ischemia/reperfusion syndrome. The parameters that were determined are the following: CPK, P, CRP, Ht, Hb, WBC, PLT. Were also measured the MDA (malondialdeyde) levels of the small bowel tissue, the levels of lactate levels in the blood and the enteric tissue. Finally, the IR injury was assessed by changes in mucosal integrity and brush border disaccharidase activities. Small bowel tissue samples were taken for light and electron microscope study. Animals of group A were subjected to laparotomy alone, sham group. The rabbits of group B were subjected to acute ischemia-reperfusion without administration of oxygenated perfluorocarbons. In group C, rabbits were subjected to acute ischemia reperfusion with administration of oxygenated perfluorocarbons 30 min before the ischemic period, whereas, in group D, the oxygenated perfluorocarbons were administrated 60 min after the onset of the ischemic period. In this experimental study was assessed that injuries of reperfusion are major compared to the ones of mere ischemia, as observed by the measurement of a significant factor of lipid peroxidation against ROS production, like MDA. Moreover, the variation of the lactate values was analyzed, both in the serum and in the bowel tissue, along with mucosal dissacharidase activity, and the results of the electronic microscope, which all led to the former outcome. The benefits of PFC are observed in the different values of the factors mentioned before in groups C and D. In these groups, MDA, lactate and dissacharidase values noted a statistically significant decrease, especially in perspective of the group B, where no PFC was administrated after IR. Among groups C and D, the alteration of the mean of group C indicates better results. This is explained by the fact that in group C, PFC is administrated 30 min previous to the ischemia. It is thought possible that early administration of PFC provides such an oxygen sufficiency that can preserve a substantial part of the bowel tissue structure. Thereby, ischemia injuries are eliminated and, consequently, the impending reperfusion in group C better than group D, where oxygen appears at the middle of the ischemic period. Ischemic injuries in group D seem to be reversible and, by providing PFC, reperfusion injuries become less intense, compared to the ones of group B. Light microscope revealed that the histological condition of the bowel tissue was distinctly worse at the animals of group B, with prominent deterioration of the villi morphology. On the contrary, animals of groups C and D, where PFC was administered, had less deterioration according to the Chiu classification. The comparison between the groups that used PFC, revealed a better condition of the tissue sections of group C. Electron microscope showed deterioration of mucosal cells in group B, (mitochondria swelling, apoptosis of cristae) as well in 120 min of ischemia as in 180 min of reperfusion. Similar deterioration was noticed when PFC was administered even though of a less intense effect than the ones of the corresponding experimental times of group B. Similarly as with the light microscope, group C presented the least intense deterioration of tissue section amongst the groups that received PFC. In conclusion, administration of PFC alternates the unfavorable outcome that the IR syndrome induces, since it constrains the bowel mucosa injuries. Intraluminal use of PFC can not substitute surgical reperfusion, when needed, but seems to increase the time interval for the surgery to occur.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ntinas, Achilleas
- Ντίνας, Αχιλλέας
Subjects
dc:subject × 14- Εντερικές βλάβες ισχαιμίας-επαναιμάτωσης
- Φθοριοάνθρακες
- Γαλακτικό οξύ
- Μαλονική διαλδεΰδη (MDA)
- Δισακχαριδάσεις εντερικού βλεννογόνου
- Intestinal ischemia-reperfusion injury
- Perfluorocarbons
- Lactate
- MDA
- Mucosal dissacharidase activity
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19483